McAllister J C
Am J Hosp Pharm. 1985 Jun;42(6):1370-3.
In this concluding installment in a multipart series, issues that should be considered in the improvement of hospital pharmacy purchasing and inventory control systems are presented. Pharmacists must be aware of possible variation in bioavailability among different formulations of the same drug and evaluate new vendors critically. Hospital pharmacists and industry representatives should strive for a cooperative relationship by fostering ongoing dialogue. Pharmacists must continue to demand competitive bid prices on generically equivalent products of equal quality. Firm contact prices cannot be expected if product use estimates are unreliable. It is unethical to encourage additional price reductions on competitive products after a formal bid has been received. Institutions should limit their participation to one group purchasing organization or wholesaler for the competitive bid process. Inventory management through methods such as ABC analysis, economic-order quantities, calculated optimum reorder points, and other quantitative measurements should become commonplace. The use of data processing systems and devices can enable pharmacists to become more proficient at pharmaceutical purchasing and inventory control. The acquisition and distribution of pharmaceuticals in health-care institutions require good management to capture the opportunities in this area for pharmacy to contribute to fiscally sound health care.
在这个多部分系列的最后一部分中，将介绍改善医院药房采购和库存控制系统时应考虑的问题。药剂师必须意识到同一药物不同剂型之间生物利用度可能存在的差异，并严格评估新供应商。医院药剂师和行业代表应通过促进持续对话来建立合作关系。药剂师必须继续要求对质量相当的通用等效产品提供有竞争力的投标价格。如果产品使用估计不可靠，就不能期望有确定的合同价格。在收到正式投标后鼓励对竞争性产品进一步降价是不道德的。机构在竞争性投标过程中应将参与限制在一个集团采购组织或批发商。通过ABC分析、经济订货量、计算出的最佳再订货点等方法以及其他定量测量进行库存管理应成为常态。使用数据处理系统和设备可以使药剂师在药品采购和库存控制方面更加熟练。医疗机构中药品的采购和分发需要良好的管理，以抓住该领域的机会，使药房能够为财政健全的医疗保健做出贡献。
